Galectin Therapeutics updates corporate presentation; no material new disclosures

GALECTIN THERAPEUTICS INC

Filed updated corporate presentation on January 13, 2025, available on company website.
Presentation intended for use at investor conferences and meetings.
No specific pipeline, financial, or clinical milestones disclosed in the filing.

item 7.01 item 9.01

GALECTIN THERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0001140361-25-000879

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.